A new study published in Neurology suggests that medications commonly prescribed for an enlarged prostate might also reduce the risk of developing dementia with Lewy bodies (LBD), a neurodegenerative disorder impacting memory, movement, and cognition.
The Study
Researchers from the University of Iowa and the University of Michigan investigated whether three prostate drugs—terazosin, doxazosin, and alfuzosin—might offer protective effects against dementia with Lewy bodies.These commonly prescribed alpha-blockers are typically used to treat benign prostatic hyperplasia (BPH), a condition marked by an enlarged prostate. By relaxing the muscles in the prostate and bladder neck, these medications help alleviate symptoms such as frequent or painful urination.
